Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Cell Therapy/Immunotherapy Patients”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT01863108
What this trial is testing

Safety Study of a Dendritic Cell-based Cancer Vaccine in Melanoma

Who this might be right for
MelanomaTumor VaccinesEffects of Immunotherapy
University Hospital, Grenoble 9
Not applicableEnded earlyNCT05812274
What this trial is testing

Apricity CARE to Improve ICI Outcomes of Ethnic/Racial Minority NSCLC Patients

Who this might be right for
Non Small Cell Lung Cancer
Columbia University 30
Not applicableUnknownNCT04359199
What this trial is testing

QUantitative Assessment of Swallowing After Radiation (QUASAR)

Who this might be right for
Head and Neck CancerDysphagiaOropharyngeal Dysphagia+2 more
Loren Mell, MD 42
Early research (Phase 1)UnknownNCT06556004
What this trial is testing

Phase 1 Study Using TRIMELVax for Stage IIIC / IV Melanoma Patients

Who this might be right for
Melanoma Stage IIIcMelanoma Stage IV
University of Chile 20
Testing effectiveness (Phase 2)Active Not RecruitingNCT05796089
What this trial is testing

Chemotherapy and Immunotherapy in Extensive-Stage Small-Cell Lung Cancer With Thoracic Radiotherapy

Who this might be right for
Extensive-Stage Small-Cell Lung Cancer
Trans Tasman Radiation Oncology Group 35
Large-scale testing (Phase 3)Looking for participantsNCT05085028
What this trial is testing

A Randomised Open-label Phase III Trial of REduced Frequency Pembrolizumab immuNothErapy for First-line Treatment of Patients With Advanced Non-small Cell Lung Cancer (NSCLC)

Who this might be right for
Lung Cancer, Nonsmall Cell
Imperial College London 1,750
Early research (Phase 1)Study completedNCT02010606
What this trial is testing

Phase I Study of a Dendritic Cell Vaccine for Patients With Either Newly Diagnosed or Recurrent Glioblastoma

Who this might be right for
GlioblastomaGlioblastoma MultiformeGlioma+2 more
Cedars-Sinai Medical Center 39
Early research (Phase 1)Study completedNCT00057915
What this trial is testing

Vaccine Therapy in Treating Patients With Refractory Stage IV Cancer

Who this might be right for
Unspecified Adult Solid Tumor, Protocol Specific
Duke University 4
Not applicableEnded earlyNCT02170389
What this trial is testing

Vaccine Therapy Before Surgery in Treating Patients With Localized Kidney Cancer

Who this might be right for
Recurrent Renal Cell CarcinomaStage I Renal Cell CancerStage II Renal Cell Cancer
Roswell Park Cancer Institute 5
Early research (Phase 1)Looking for participantsNCT06942143
What this trial is testing

An Open-label, Phase I Clinical Trial of Super1 TCR-T in NY-ESO-1-positive Patients With Advanced Solid Tumors

Who this might be right for
SarcomaLung CancersMelanoma
Guangzhou FineImmune Biotechnology Co., LTD. 15
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07578025
What this trial is testing

Zanzalintinib and MO-03 for the Treatment of Metastatic Renal Cell Cancer After Progression on Immunotherapy

Who this might be right for
Metastatic Clear Cell Renal Cell CarcinomaStage IV Renal Cell Cancer AJCC v8
City of Hope Medical Center 34
Not applicableUnknownNCT03671265
What this trial is testing

Combination of Chemotherapy Plus RT and SHR-1210 to Treat Patients With ESCC

Who this might be right for
Esophageal Cancer
Tianjin Medical University Cancer Institute and Hospital 20
Testing effectiveness (Phase 2)Study completedNCT02631447
What this trial is testing

Sequential Combo Immuno and Target Therapy (SECOMBIT) Study

Who this might be right for
Metastatic Melanoma
Fondazione Melanoma Onlus 251
Testing effectiveness (Phase 2)Study completedNCT02799238
What this trial is testing

Autologuos Lymphoid Effector Cells Specific Against Tumour (ALECSAT) as Add on to Standard of Care in Patients With Glioblastoma

Who this might be right for
Glioblastoma
CytoVac A/S 62
Early research (Phase 1)Study completedNCT01137006
What this trial is testing

An Open-Label, Dose-Escalation Study of IMC-20D7S In Participants With Malignant Melanoma

Who this might be right for
Malignant Melanoma
Eli Lilly and Company 27
Testing effectiveness (Phase 2)Study completedNCT04263090
What this trial is testing

Rigosertib Plus Nivolumab for KRAS+ NSCLC Patients Who Progressed on First-Line Treatment

Who this might be right for
Non-small Cell Lung CancerAdenocarcinomaStage IV
Icahn School of Medicine at Mount Sinai 25
Testing effectiveness (Phase 2)Looking for participantsNCT06640582
What this trial is testing

TIL Therapy Combined With Pembrolizumab for Advanced Brain Cancer Including Gliomas and Meningiomas

Who this might be right for
Brain TumorBrain MetastasesBrain Cancer+4 more
Essen Biotech 85
Not applicableLooking for participantsNCT06428422
What this trial is testing

The Impact of Probiotic on Survival and Treatment Response in Metastatic Non-small Cell Lung Cancer Patients

Who this might be right for
Metastatic Non-small Cell Lung Cancer
Necmettin Erbakan University 100
Early research (Phase 1)UnknownNCT05928962
What this trial is testing

An Exploratory Single-arm Study: PD-1 With Recombinant Human Adenovirus Type 5 Injection for Malignant Melanomas

Who this might be right for
Malignant Melanomas
Fujian Cancer Hospital 10
Not applicableStudy completedNCT00005956
What this trial is testing

Biological Therapy in Treating Patients With Advanced Cancer

Who this might be right for
Breast CancerGastric CancerOvarian Cancer
Duke University 3
Next Page